IL6 and breast cancer: In turn, blocking IL-6 resulted in a reduction of BC tumour growth and invasive ability due to a decrease in cell proliferation, lower epithelial–mesenchymal transition, reduced DNA methyltransferase 1 expression and attenuated angiogenesis [154].